<div class='circular--portrait' style='background:#800000;color: #F8F8FF;font-size:4em;padding-top: 25px;;'>IT</div>
IGNT -- USA Stock  

USD 0.0001  0.0001  50.00%

Mr. Thomas J. Neavitt is Chief Financial Officer, Director of Ingen Technologies Inc. He was appointed as Director of the Company on April 15, 2013. He was appointed as Interim Chief Executive Officer of the Company on February 14, 2011. He has held a variety of executive level positions for product and service based corporations over the last 40 years. Mr. Neavitt experience includes finance, marketing, business development, sales, and collections. Additionally, Mr. Neavitt has experience in real estate as both a broker and developer. Mr. Neavitt served in the U.S. Navy. Mr. Neavitt left the Navy and became President and CEO of PennAkron Corporationrationration and its wholly owned subsidiary Eagle Lock Corporationrationration. He was instrumental in the acquisition of this company. Mr. Neavitt also served as President of TR3 Chemical Corporationrationration for nearly 20 years who sold products throughout the U.S. and some foreign countries. Tom now serves as a consultant to various corporations throughout the country
  CEO Since 2014      
Neavitt was President of AmTech Corporationrationrationration, which manufactures stabilizing systems, for the past 5 years.

INGEN TECHNOLOGIES Management Efficiency

INGEN TECHNOLOGIES INC has return on total asset (ROA) of (2.02) % which means that it has lost $2.02 on every $100 spent on asset. This is way below average. INGEN TECHNOLOGIES management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities.
The company currently holds 4.76 M in liabilities. INGEN TECHNOLOGIES INC has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due.

Similar Executives

Found 9 records

CEO Since

Robert FordAbbott Laboratories
David DvorakZimmer Biomet Holdings
Rene SvendsenTuneGn Store Nord
Anders HedegaardGn Store Nord
Jakob GudbrandGn Store Nord
Bryan HansonZimmer Biomet Holdings
Rene SvendsenTuneGn Store Nord
Jakob GudbrandGn Store Nord
Anders HedegaardGn Store Nord

Company Summary

Ingen Technologies, Inc., a medical device manufacturing company, manufactures medical products for the respiratory industry in United States. Ingen Technologies, Inc. was founded in 1999 and is based in Riverside, California. INGEN TECHNOLOGIES operates under Medical Devices classification in the United States and is traded on BATS Exchange.INGEN TECHNOLOGIES INC [IGNT] is traded as part of a regulated electronic over-the-counter service offered by the NASD.


Christopher Wirth, Director
Stephen OHara, Director
John Finazzo, Director
Yong Khoo, Director
Thomas Neavitt, Interim CEO, CFO, Principal Accounting Officer, Controller and Director
Richard Campbell, Director
David Hanson, CEO
Charles Vorwaller, Executive VP of National Product Distribution
David Holland, Director
Gary Tilden, Chairman, Chief Operations Officer and Secretary
Curt Miedema, Director
Donn Miller, Director
Michael Cooper, Director

Stock Performance Indicators

Current Sentiment - IGNT


Macroaxis portfolio users are indifferent in their judgment towards investing in INGEN TECHNOLOGIES INC. What is your judgment towards investing in INGEN TECHNOLOGIES INC? Are you bullish or bearish?
50% Bullish
50% Bearish

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Risk vs Return Analysis. Please also try Shere Portfolio module to track or share privately all of your investments from the convenience of any device.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page